O'Brien J M, Cidlowski J A
Biochemistry. 1982 Oct 26;21(22):5644-50. doi: 10.1021/bi00265a040.
5'-Deoxypyridoxal, a vitamin B-6 analogue, increased the rate of dissociation of [3H]dexamethasone from HeLa S3 cytoplasmic glucocorticoid receptor complexes in vitro. This effect was achieved at millimolar concentrations of 5'-deoxypyridoxal, suggesting a low-affinity interaction of 5'-deoxypyridoxal with receptor. Loss of [3H]dexamethasone-receptor binding in the presence of 5'-deoxypyridoxal was pH dependent, and a plot of Kdiss vs. pH fit a simple sigmoidal titration curve with an inflection point at pH 7.8, suggesting that deprotonation of a single functional group on 5'-deoxypyridoxal increases Kdiss. Loss of [3H]dexamethasone binding in the presence or absence of unlabeled steroid also increased with pH, but no inflection point occurred over the range of pH tested. A titration of 5'-deoxypyridoxal indicated a pK of 7.94 for the pyridinium proton, suggesting deprotonation of the pyridinium nitrogen may account for the pH dependence of Kdiss of dexamethasone from receptor. 5'-Deoxypyridoxal also caused a decrease in nuclear [3H]-dexamethasone-receptor binding when incubated with whole HeLa S3 cells at 37 degrees C. Furthermore, 5'-deoxypyridoxal was effective in reducing nuclear binding of dexamethasone when added either simultaneously with [3H]dexamethasone or after achievement of equilibrium of steroid with receptor. The reduction in nuclear [3H]dexamethasone binding is highly specific for 5'-deoxypyridoxal. Several analogues of this compound, including 5'-deoxypyridoxamine, were ineffective. In addition, this effect was reversible following removal of extracellular 5'-deoxypyridoxal. Under these conditions, 5'-deoxypyridoxal was competitive with dexamethasone for binding to nuclear receptor, with KI = 8.1 X 10(-6) M. Scatchard plot analysis of dexamethasone-receptor binding in the presence or absence of 5'-deoxypyridoxal was consistent with an apparent reduced affinity of [3H]dexamethasone for receptor, which again suggests competitive interaction or allosteric interaction mediated dissociation. Glucocorticoids are known to stimulate alkaline phosphatase activity within HeLa S3 cells. In whole cell incubations, 5'-deoxypyridoxal was effective in reducing the dexamethasone-induced increase in alkaline phosphatase activity by 60% under conditions in which cell viability and cell growth were not affected.
5'-脱氧吡哆醛是一种维生素B-6类似物,它在体外能提高[3H]地塞米松从HeLa S3细胞质糖皮质激素受体复合物上的解离速率。这种效应在5'-脱氧吡哆醛的毫摩尔浓度下即可实现,这表明5'-脱氧吡哆醛与受体的相互作用亲和力较低。在5'-脱氧吡哆醛存在的情况下,[3H]地塞米松-受体结合的丧失呈pH依赖性,Kdiss对pH作图拟合一条简单的S形滴定曲线,拐点在pH 7.8处,这表明5'-脱氧吡哆醛上单个官能团的去质子化会增加Kdiss。无论有无未标记的类固醇存在,[3H]地塞米松结合的丧失也随pH升高而增加,但在所测试的pH范围内未出现拐点。对5'-脱氧吡哆醛的滴定表明吡啶鎓质子的pK为7.94,这表明吡啶鎓氮的去质子化可能是地塞米松从受体上解离的Kdiss呈pH依赖性的原因。当在37℃下与完整的HeLa S3细胞一起孵育时,5'-脱氧吡哆醛也会导致细胞核中[3H]-地塞米松-受体结合减少。此外,当与[3H]地塞米松同时添加或在类固醇与受体达到平衡后添加时,5'-脱氧吡哆醛能有效降低地塞米松的细胞核结合。细胞核中[3H]地塞米松结合的减少对5'-脱氧吡哆醛具有高度特异性。该化合物的几种类似物,包括5'-脱氧吡哆胺,均无效。此外,去除细胞外的5'-脱氧吡哆醛后,这种效应是可逆的。在这些条件下,5'-脱氧吡哆醛与地塞米松竞争结合细胞核受体,KI = 8.1×10(-6)M。在有或无5'-脱氧吡哆醛存在的情况下对地塞米松-受体结合进行Scatchard作图分析,结果与[3H]地塞米松对受体的表观亲和力降低一致,这再次表明存在竞争性相互作用或变构相互作用介导的解离。已知糖皮质激素能刺激HeLa S3细胞内的碱性磷酸酶活性。在全细胞孵育中,在不影响细胞活力和细胞生长的条件下,5'-脱氧吡哆醛能有效降低地塞米松诱导的碱性磷酸酶活性增加60%。